Table 7. Stage, genotype, and pathological classification of lung adenocarcinoma patients.
Patient ID | Genotype | Stage |
---|---|---|
3437 | EGFR+/KRAS- | IA |
4838 | EGFR+/KRAS- | 1A |
4837 | EGFR+/KRAS- | 1B |
4839 | EGFR+/KRAS- | 1B |
4842 | EGFR+/KRAS- | 2A |
4840 | EGFR+/KRAS- | 2B |
4841 | EGFR+/KRAS- | 2B |
4843 | EGFR+/KRAS- | 3A |
4844 | EGFR+/KRAS- | 3A |
4845 | EGFR+/KRAS- | 3A |
4848 | KRAS+/EGFR- | 1A |
4849 | KRAS+/EGFR- | 1A |
4846 | KRAS+/EGFR- | 1B |
4847 | KRAS+/EGFR- | 1B |
4850 | KRAS+/EGFR- | 2B |
4851 | KRAS+/EGFR- | 2B |
4852 | KRAS+/EGFR- | 2B |
4853 | KRAS+/EGFR- | 2B |
4854 | KRAS+/EGFR- | 3A |
4855 | KRAS+/EGFR- | 3A |
4856 | KRAS+/EGFR- | 3B |